Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) appointed Wang Lei as chairman of the board, according to a Tuesday filing on the Singapore Exchange.
Wang has been with the company since 1993 and has held key roles including general manager and executive director. She holds a doctorate in engineering and is a senior engineer.
Wang succeeded Zhang Mingrui, who resigned from the post, effective Nov. 25, due to a change in work assignments, according to a separate filing on the same day.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.